Parallel Advisors, LLC Vir Biotechnology, Inc. Transaction History

Parallel Advisors, LLC

  • $4.18 Billion
  • Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 512 shares of VIR stock, worth $3,788. This represents 0.0% of its overall portfolio holdings.

Number of Shares
512
Previous 777 34.11%
Holding current value
$3,788
Previous $6,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$7.26 - $10.7 $1,923 - $2,835
-265 Reduced 34.11%
512 $3,000
Q2 2024

Aug 08, 2024
SELL
$7.63 - $12.66 $564 - $936
-74 Reduced 8.7%
777 $6,000
Q4 2023

Feb 09, 2024
BUY
$7.76 - $10.29 $2,731 - $3,622
352 Added 70.54%
851 $8,000
Q3 2023

May 20, 2024
SELL
$9.14 - $24.62 $45 - $123
-5 Reduced 0.99%
499 $4,000
Q3 2023

Nov 13, 2023
SELL
$9.14 - $24.62 $45 - $123
-5 Reduced 0.99%
499 $4,000
Q2 2023

May 20, 2024
SELL
$23.2 - $27.29 $1,693 - $1,992
-73 Reduced 12.65%
504 $12,000
Q2 2023

Aug 04, 2023
SELL
$23.2 - $27.29 $1,693 - $1,992
-73 Reduced 12.65%
504 $12,000
Q1 2023

May 20, 2024
SELL
$22.26 - $30.85 $6,099 - $8,452
-274 Reduced 32.2%
577 $13,000
Q1 2023

Apr 25, 2023
BUY
$22.26 - $30.85 $12,621 - $17,491
567 Added 5670.0%
577 $13,000
Q4 2022

Feb 03, 2023
SELL
$19.96 - $28.22 $139 - $197
-7 Reduced 41.18%
10 $0
Q3 2022

Nov 10, 2022
SELL
$18.26 - $31.1 $109 - $186
-6 Reduced 26.09%
17 $0
Q2 2022

Aug 01, 2022
BUY
$19.08 - $26.7 $248 - $347
13 Added 130.0%
23 $1,000
Q1 2022

Apr 28, 2022
SELL
$21.19 - $40.01 $932 - $1,760
-44 Reduced 81.48%
10 $0
Q4 2021

Jan 20, 2022
SELL
$30.97 - $54.03 $641,853 - $1.12 Million
-20,725 Reduced 99.74%
54 $2,000
Q3 2021

Nov 02, 2021
SELL
$34.9 - $54.54 $362,366 - $566,288
-10,383 Reduced 33.32%
20,779 $904,000
Q2 2021

Aug 06, 2021
BUY
$38.75 - $51.0 $866,605 - $1.14 Million
22,364 Added 254.19%
31,162 $1.47 Million
Q1 2021

Apr 23, 2021
SELL
$26.34 - $83.07 $126,089 - $397,656
-4,787 Reduced 35.24%
8,798 $451,000
Q3 2020

Oct 27, 2020
BUY
$28.28 - $53.6 $354,291 - $671,500
12,528 Added 1185.24%
13,585 $466,000
Q2 2020

Jul 16, 2020
BUY
$27.89 - $47.86 $29,479 - $50,588
1,057 New
1,057 $43,000

Others Institutions Holding VIR

# of Institutions
218
Shares Held
87M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $982M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email